Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

57.46
Delayed Data
As of Dec 02
 +0.57 / +1.00%
Today’s Change
28.01
Today|||52-Week Range
60.98
+38.46%
Year-to-Date
No recent news for Five Prime Therapeutics Inc.

Today’s Trading

Previous close56.89
Today’s open56.89
Day’s range56.67 - 58.65
Volume274,067
Average volume (3 months)417,787
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-124.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,874.94%
P/E ratio6.1
Price/Sales2.95
Price/Book3.46

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc-1.25-2.20%
ONCESpark Therapeutics I...+0.27+0.54%
EXASExact Sciences Corp+0.34+2.49%
HALOHalozyme Therapeutic...+0.14+1.25%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$379.8M
Annual profit (last year)$249.6M
Net profit margin65.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Lewis T. Williams
Chief Operating Officer &
Director
Aron M. Knickerbocker
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs